{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T00:44:52Z","timestamp":1794098692373,"version":"4.8.0"},"reference-count":89,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1097\/01.ftd.0000245377.93401.39","type":"journal-article","created":{"date-parts":[[2006,10,18]],"date-time":"2006-10-18T15:26:16Z","timestamp":1161185176000},"page":"577-584","source":"Crossref","is-referenced-by-count":44,"title":["Sirolimus - Challenging Current Perspectives"],"prefix":"10.1097","volume":"28","author":[{"given":"Irina","family":"Buhaescu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Izzedine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Covic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210129","doi-asserted-by":"crossref","first-page":"28E","DOI":"10.1208\/aapsj060428","article-title":"Exposure-response relationships and drug interactions of sirolimus.","volume":"6","author":"Zimmerman","year":"2004","journal-title":"AAPS J"},{"key":"R2-1-20210129","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1681\/ASN.V1061366","article-title":"Newer immunosuppressive drugs: A review.","volume":"10","author":"Gummert","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R3-1-20210129","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.ftd.0000179838.33020.34","article-title":"Pharmacokinetics and metabolic disposition of sirolimus in healthy male volunteers after a single oral dose.","volume":"28","author":"Leung","year":"2006","journal-title":"Ther Drug Monit"},{"key":"R4-1-20210129","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1097\/00007691-199512000-00022","article-title":"Consensus guidelines for therapeutic drug monitoring of rapamycin: Report of the consensus panel.","volume":"17","author":"Yatscoff","year":"1995","journal-title":"Ther Drug Monit"},{"key":"R5-1-20210129","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1034\/j.1399-0012.2000.140201.x","article-title":"Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity.","volume":"14","author":"Kahan","year":"2000","journal-title":"Clin Transplant"},{"key":"R6-1-20210129","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2165\/00003088-200544080-00001","article-title":"Sirolimus: the evidence for clinical pharmacokinetic monitoring.","volume":"44","author":"Stenton","year":"2005","journal-title":"Clin Pharmacokinet"},{"key":"R7-1-20210129","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/clinchem\/37.2.294","article-title":"High-performance liquid chromatography of rapamycin.","volume":"37","author":"Napoli","year":"1991","journal-title":"Clin Chem"},{"key":"R8-1-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/00007691-199702000-00022","article-title":"Determination of rapamycin in whole blood by HPLC.","volume":"19","author":"Svensson","year":"1997","journal-title":"Ther Drug Monit"},{"key":"R9-1-20210129","doi-asserted-by":"crossref","first-page":"71B","DOI":"10.1016\/S0149-2918(00)89024-4","article-title":"The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients.","volume":"22","author":"Salm","year":"2000","journal-title":"Clin Ther"},{"key":"R10-1-20210129","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/S0140-6736(00)02480-6","article-title":"S. Study Group. Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study.","volume":"356","author":"Kahan","year":"2000","journal-title":"Lancet"},{"key":"R11-1-20210129","doi-asserted-by":"crossref","first-page":"37S","DOI":"10.1016\/S0041-1345(03)00353-1","article-title":"Two-year results of multicenter phase III trials of the effect of the addition of sirolimus to cyclosporine-based immunosuppressive regimens in renal Transplantation.","volume":"35","author":"Kahan","year":"2003","journal-title":"Transplant Proc"},{"key":"R12-1-20210129","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-200101270-00019","article-title":"A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus\/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.","volume":"71","author":"MacDonald","year":"2001","journal-title":"Transplantation"},{"key":"R13-1-20210129","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1111\/j.1600-6143.2005.01055.x","article-title":"A randomized controlled trial of late conversion from CNI-based to sirolimus-based immunosuppression following renal Transplantation.","volume":"5","author":"Watson","year":"2005","journal-title":"Am J Transplant"},{"key":"R14-1-20210129","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1097\/00007890-200109150-00007","article-title":"Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure.","volume":"72","author":"Johnson","year":"2001","journal-title":"Transplantation"},{"key":"R15-1-20210129","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1097\/01.TP.0000137322.65953.0A","article-title":"Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.","volume":"78","author":"Ruiz","year":"2004","journal-title":"Transplantation"},{"key":"R16-1-20210129","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.transproceed.2004.12.132","article-title":"Addition of sirolimus to cyclosporine in long-term kidney transplant recipients to withdraw steroid.","volume":"37","author":"Citterio","year":"2005","journal-title":"Transplant Proc"},{"key":"R17-1-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2004.00655.x","article-title":"A multicenter pilot study of early (4-day) steroid cessation in renal transplant recipients under simulect, tacrolimus and sirolimus.","volume":"5","author":"Woodle","year":"2005","journal-title":"Am J Transplant"},{"key":"R18-1-20210129","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.transproceed.2004.12.129","article-title":"A prospective, pilot study of early corticosteroid cessation in high-immunologic-risk patients: the Cincinnati experience.","volume":"37","author":"Alloway","year":"2005","journal-title":"Transplant Proc"},{"key":"R19-1-20210129","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1399-0012.2005.00329.x","article-title":"Rapamycin in patients with chronic renal allograft dysfunction.","volume":"19","author":"Wu","year":"2005","journal-title":"Clin Transplant"},{"key":"R20-1-20210129","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000079808","article-title":"Low-dose sirolimus in combination with mycophenolate mofetil improves kidney graft function late after renal transplantation and suggests pharmacokinetic interaction of both immunosuppressive drugs.","volume":"27","author":"Renders","year":"2004","journal-title":"Kidney Blood Press Res"},{"key":"R21-1-20210129","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/j.transproceed.2004.08.005","article-title":"Sirolimus in chronic allograft nephropathy.","volume":"36","author":"Wu","year":"2004","journal-title":"Transplant Proc"},{"key":"R22-1-20210129","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.transproceed.2005.12.023","article-title":"Conversion to sirolimus from cyclosporine may induce nephrotic proteinuria and progressive deterioration of renal function in chronic allograft nephropathy patients.","volume":"38","author":"Boratynska","year":"2006","journal-title":"Transplant Proc"},{"key":"R23-1-20210129","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1097\/00007890-200105150-00025","article-title":"A calcineurin antagonist-free induction strategy for immunosuppression in cadaveric kidney transplant recipients at high risk for delayed graft function.","volume":"71","author":"Hong","year":"2001","journal-title":"Transplantation"},{"key":"R24-1-20210129","first-page":"153","article-title":"Benefit-risk assessment of sirolimus in renal Transplantation Drug Saf.","volume":"28","author":"Kuypers","year":"2005","journal-title":""},{"key":"R25-1-20210129","doi-asserted-by":"crossref","first-page":"541","DOI":"10.4065\/79.4.541","article-title":"Sirolimus-associated diffuse alveolar hemorrhage.","volume":"79","author":"Vlahakis","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"R26-1-20210129","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.transproceed.2006.01.052","article-title":"Resolution of sirolimus-induced pneumonitis after conversion to everolimus.","volume":"38","author":"Rehm","year":"2006","journal-title":"Transplant Proc"},{"key":"R27-1-20210129","doi-asserted-by":"crossref","first-page":"505","DOI":"10.7326\/0003-4819-144-7-200604040-00009","article-title":"Brief communication: sirolimus-associated pneumonitis: 24 cases in renal transplant recipients.","volume":"144","author":"Champion","year":"2006","journal-title":"Ann Intern Med"},{"key":"R28-1-20210129","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1097\/00007890-200109150-00008","article-title":"Characteristics of sirolimus associated interstitial pneumonitis in renal transplant recipients.","volume":"72","author":"Morelon","year":"2001","journal-title":"Transplantation"},{"key":"R29-1-20210129","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1399-0012.2005.00356.x","article-title":"Sirolimus-associated interstitial pneumonitis in solid organ transplant recipients.","volume":"19","author":"Garrean","year":"2005","journal-title":"Clin Transplant"},{"key":"R30-1-20210129","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1111\/j.1600-6143.2004.00429.x","article-title":"Sirolimus-induced angioedema.","volume":"4","author":"Wadei","year":"2004","journal-title":"Am J Transplant"},{"key":"R31-1-20210129","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1097\/01.TP.0000151630.25127.3A","article-title":"Cutaneous adverse events in renal transplant recipients receiving sirolimus-based therapy.","volume":"79","author":"Mahe","year":"2005","journal-title":"Transplantation"},{"key":"R32-1-20210129","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00075198-200112000-00003","article-title":"Nephrotoxicity of immunosuppressive drugs: new insight and preventive strategies.","volume":"7","author":"Olyaei","year":"200","journal-title":"Curr Opin Crit Care"},{"key":"R33-1-20210129","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1034\/j.1600-6143.2002.20507.x","article-title":"Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.","volume":"2","author":"Morales","year":"2002","journal-title":"Am J Transplant"},{"key":"R34-1-20210129","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199203000-00002","article-title":"The effect of rapamycin on kidney function in the Sprague-Dawley rat.","volume":"53","author":"DiJoseph","year":"1992","journal-title":"Transplantation"},{"key":"R35-1-20210129","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00041552-199911000-00001","article-title":"The nephropatic nature of proteinuria.","volume":"8","author":"Remuzzi","year":"1999","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R36-1-20210129","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1046\/j.1523-1755.2000.00342.x","article-title":"Progressive adriamycin nephropathy in mice: sequence of histologic and immunohistochemical events.","volume":"58","author":"Wang","year":"2000","journal-title":"Kidney Int"},{"key":"R37-1-20210129","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1681\/ASN.2005050504","article-title":"Rapamycin: a new string to the antiproteinuric bow?","volume":"16","author":"Brunskill","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R38-1-20210129","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1681\/ASN.V1071487","article-title":"Activation of mithogic pathways by albumin in kidney proximal tubule epithelial cells: implications for the pathophysiology of proteinuric states.","volume":"10","author":"Dixon","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R39-1-20210129","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1111\/j.1523-1755.2005.00350.x","article-title":"Rapamycin inhibits human renal epithelial cell proliferation: effect on cyclin D3 mRNA expression and stability.","volume":"67","author":"Pallet","year":"2005","journal-title":"Kidney Int"},{"key":"R40-1-20210129","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0952-7915(01)00275-8","article-title":"Dendritic cells in autoimmune diseases.","volume":"13","author":"Ludewig","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"R41-1-20210129","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","article-title":"Rapamycin inhibits IL4-induced dendritic cell maturation in vitro and dendritic cell mobilisation and function in vivo.","volume":"101","author":"Hackstein","year":"2003","journal-title":"Blood"},{"key":"R42-1-20210129","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1681\/ASN.2004030180","article-title":"Rapamycin ameliorates proteinuria-associated tubulointerstitial inflammation and fibrosis in experimental membranous nephropathy.","volume":"16","author":"Bonegio","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R43-1-20210129","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R44-1-20210129","first-page":"1811","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).","volume":"12","author":"Wahl","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R45-1-20210129","first-page":"419","article-title":"mTOR inhibitors in hematologic malignancies.","volume":"1","author":"Dancey","year":"2003","journal-title":"Clin Adv Hematol Oncol"},{"key":"R46-1-20210129","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2141.2005.05600.x","article-title":"Control of advanced and refractory acute myelogenous leukaemia with sirolimus-based non-myeloablative allogeneic stem cell Transplantation.","volume":"130","author":"Claxton","year":"2005","journal-title":"Br J Haematol"},{"key":"R47-1-20210129","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1182\/blood-2005-03-0929","article-title":"Rapamycin stimulates apoptosis of childhood acute lymphoblastic leukemia cells.","volume":"106","author":"Avellino","year":"2005","journal-title":"Blood"},{"key":"R48-1-20210129","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/02841860510044610","article-title":"Impressive regression of primary liver cancer after treatment with sirolimus.","volume":"44","author":"Rizell","year":"2005","journal-title":"Acta Oncol"},{"key":"R49-1-20210129","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.transproceed.2005.03.013","article-title":"Successful use of sirolimus in a patient with bulky ovarian metastasis of hepatocellular carcinoma after liver Transplantation.","volume":"37","author":"Stippel","year":"2005","journal-title":"Transplant Proc"},{"key":"R50-1-20210129","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1097\/01.TP.0000154913.88193.FF","article-title":"Complete remission of postransplant lung metastases from hepatocellular carcinoma under therapy with sirolimus and mycophenolate mofetil.","volume":"79","author":"Elsharkawi","year":"2005","journal-title":"Transplantation"},{"key":"R51-1-20210129","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1158\/0008-5472.CAN-04-4589","article-title":"Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"key":"R52-1-20210129","doi-asserted-by":"crossref","first-page":"5319","DOI":"10.1158\/1078-0432.CCR-04-2402","article-title":"Dual inhibition of mTOR and estrogen receptor signaling in vitro induces cell death in models of breast cancer.","volume":"11","author":"Boulay","year":"2005","journal-title":"Clin Cancer Res"},{"key":"R53-1-20210129","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.1158\/0008-5472.CAN-04-4589","article-title":"Antitumor activity of rapamycin in a transgenic mouse model of ErbB2-dependent human breast cancer.","volume":"65","author":"Liu","year":"2005","journal-title":"Cancer Res"},{"key":"R54-1-20210129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1158\/1541-7786.MCR-05-0007","article-title":"Pim family kinases enhance tumor growth of prostate cancer cells.","volume":"3","author":"Chen","year":"2005","journal-title":"Mol Cancer Res"},{"key":"R55-1-20210129","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s00240-002-0282-1","article-title":"Rapamycin induces Smad activity in prostate cancer cell lines.","volume":"30","author":"van der Poel","year":"2003","journal-title":"Urol Res"},{"key":"R56-1-20210129","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1158\/1078-0432.CCR-0629-3","article-title":"Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer.","volume":"10","author":"Boffa","year":"2004","journal-title":"Clin Cancer Res"},{"key":"R57-1-20210129","first-page":"3895","article-title":"Rapamycin inhibits constitutive p70s6k phosphorylation, cell proliferation, and colony formation in small cell lung cancer cells.","volume":"56","author":"Seufferlein","year":"1996","journal-title":"Cancer Res"},{"key":"R58-1-20210129","first-page":"903","article-title":"Rapamycin selectively inhibits the growth of childhood rhabdomyosarcoma cells through inhibition of signaling via the type I insulin-like growth factor receptor.","volume":"54","author":"Dilling","year":"1994","journal-title":"Cancer Res"},{"key":"R59-1-20210129","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1158\/0008-5472.CAN-04-3135","article-title":"Rapamycin inhibits ezrin-mediated metastatic behavior in a murine model of osteosarcoma.","volume":"65","author":"Wan","year":"2005","journal-title":"Cancer Res"},{"key":"R60-1-20210129","doi-asserted-by":"crossref","first-page":"9282","DOI":"10.1038\/sj.onc.1207081","article-title":"Rapamycin induces the fusion-type independent downregulation of the EWS\/FLI-1 proteins and inhibits Ewings sarcoma cell proliferation.","volume":"22","author":"Mateo-Lozano","year":"2003","journal-title":"Oncogene"},{"key":"R61-1-20210129","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1159\/000086994","article-title":"Therapeutic targeting of multiple signaling pathways in malignant pleural mesothelioma.","volume":"68","author":"Mukohara","year":"2005","journal-title":"Oncology"},{"key":"R62-1-20210129","first-page":"67S","article-title":"Cancer after kidney Transplantation G Ital Nephrol.","volume":"26","author":"Sandrini","year":"2004","journal-title":""},{"key":"R63-1-20210129","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1097\/00007890-199560120-00020","article-title":"Sarcomas in organ allograft recipients.","volume":"60","author":"Penn","year":"1995","journal-title":"Transplantation"},{"key":"R64-1-20210129","first-page":"1714","article-title":"Influence of immunosuppression on the prevalence of cancer after kidney Transplantation Transplant Proc.","volume":"35","author":"Marcen","year":"2003","journal-title":""},{"key":"R65-1-20210129","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1086\/375230","article-title":"Human herpesvirus 8: current issues.","volume":"37","author":"Cannon","year":"2003","journal-title":"Clin Infect Dis"},{"key":"R66-1-20210129","first-page":"353","article-title":"Prophylactic strategies before solid-organ Transplantation Curr Opin Infect Dis.","volume":"17","author":"Avery","year":"2004","journal-title":""},{"key":"R67-1-20210129","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1097\/01.TP.0000115344.18025.0B","article-title":"Conversion to sirolimus: a successful treatment for posttransplantation Kaposis sarcoma.","volume":"77","author":"Campistol","year":"2004","journal-title":"Transplantation"},{"key":"R68-1-20210129","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa042831","article-title":"Sirolimus for Kaposis sarcoma in renal-transplant recipients.","volume":"352","author":"Stallone","year":"2005","journal-title":"New Engl J Med"},{"key":"R69-1-20210129","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.transproceed.2004.12.172","article-title":"Regression of Kaposis sarcoma in renal graft recipients after conversion to sirolimus treatment.","volume":"37","author":"Zmonarski","year":"2005","journal-title":"Transplant Proc"},{"key":"R70-1-20210129","first-page":"366","article-title":"Complete regression of visceral Kaposis sarcoma after conversion to sirolimus.","volume":"3","author":"Mohsin","year":"2005","journal-title":"Exp Clin Transplant"},{"key":"R71-1-20210129","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1097\/01.TP.0000173770.42403.F7","article-title":"Low incidence of malignancy among sirolimus\/cyclosporine-treated renal transplant recipients.","volume":"80","author":"Kahan","year":"2005","journal-title":"Transplantation"},{"key":"R72-1-20210129","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1097\/01.TP.0000184006.43152.8D","article-title":"Maintenance Immunosuppression with Target-of-Rapamycin Inhibitors is Associated with a Reduced Incidence of De Novo Malignancies.","volume":"80","author":"Kauffman","year":"2005","journal-title":"Transplantation"},{"key":"R73-1-20210129","doi-asserted-by":"crossref","first-page":"922","DOI":"10.4049\/jimmunol.154.2.922","article-title":"Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.","volume":"154","author":"Martin","year":"1995","journal-title":"J Immunol"},{"key":"R74-1-20210129","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S0021-5155(97)00083-X","article-title":"Tacrolimus-rapamycin combination therapy for experimental autoimmune uveoretinitis.","volume":"41","author":"Ikeda","year":"1997","journal-title":"Jpn J Ophthalmol"},{"key":"R75-1-20210129","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/bjo.2004.048199","article-title":"The efficacy of sirolimus in the treatment of patients with refractory uveitis.","volume":"89","author":"Shanmuganathan","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R76-1-20210129","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1053\/j.ajkd.2005.08.037","article-title":"Thrombotic microangiopathy in marginal kidneys after sirolimus use.","volume":"46","author":"Pelle","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"R77-1-20210129","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1111\/j.1600-6143.2005.01047.x","article-title":"Sirolimus-induced thrombotic microangiopathy is associated with decreased expression of vascular endothelial growth factor in kidneys.","volume":"5","author":"Sartelet","year":"2005","journal-title":"Am J Transplant"},{"key":"R78-1-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.bbmt.2005.04.007","article-title":"Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation.","volume":"11","author":"Cutler","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"R79-1-20210129","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/01.TP.0000092522.36410.D0","article-title":"Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation.","volume":"77","author":"Paramesh","year":"2004","journal-title":"Transplantation"},{"key":"R80-1-20210129","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1034\/j.1600-6143.2003.00018.x","article-title":"Sirolimus may promote thrombotic microangiopathy.","volume":"3","author":"Saikali","year":"2003","journal-title":"Am J Transplant"},{"key":"R81-1-20210129","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ndt\/gfh079","article-title":"Acute rapamycin nephrotoxicity in native kidneys of patients with chronic glomerulopathies.","volume":"19","author":"Fervenza","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"R82-1-20210129","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1432-2277.2004.tb00431.x","article-title":"Rapamycin-associated post-transplantation glomerulonephritis and its remission after reintroduction of calcineurin-inhibitor therapy.","volume":"17","author":"Dittrich","year":"2004","journal-title":"Transplant Int"},{"key":"R83-1-20210129","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1056\/NEJM200511103531922","article-title":"Post-transplantation proteinuria and sirolimus.","volume":"353","author":"Izzedine","year":"2005","journal-title":"N Engl J Med"},{"key":"R85-1-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/ndt\/gfh639","article-title":"Nephrotoxicity of rapamycin: an emerging problem in clinical medicine.","volume":"20","author":"Marti","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"R86-1-20210129","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1111\/j.1523-1755.2004.00498.x","article-title":"Sirolimus increases transforming growth factor-beta1 expression and potentiates chronic cyclosporine nephrotoxicity.","volume":"65","author":"Shihab","year":"2004","journal-title":"Kidney Int"},{"key":"R87-1-20210129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1399-0012.2004.00116.x","article-title":"Observations regarding the use of sirolimus and tacrolimus in high-risk cadaveric renal transplantation.","volume":"18","author":"Lo","year":"2004","journal-title":"Clin Transplant"},{"key":"R88-1-20210129","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1097\/01.ASN.0000057542.86377.5A","article-title":"Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use.","volume":"14","author":"Smith","year":"2003","journal-title":"J Am Soc Nephrol"},{"key":"R89-1-20210129","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1034\/j.1600-6143.2003.00078.x","article-title":"Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation.","volume":"3","author":"McTaggart","year":"2003","journal-title":"Am J Transplant"},{"key":"R90-1-20210129","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/00007890-200301150-00029","article-title":"Severe acute renal failure after exposure to sirolimus-tacrolimus in two living donor kidney recipients.","volume":"75","author":"Lawsin","year":"2003","journal-title":"Transplantation"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/01.ftd.0000245377.93401.39","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T14:23:38Z","timestamp":1785939818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00007691-200610000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":89,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2006]]}},"URL":"https:\/\/doi.org\/10.1097\/01.ftd.0000245377.93401.39","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2006,10]]}}}